Your Catalyst To a Lucrative Business Stem Cell Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research " Increasing prevalence of chronic diseases such as diseases related to liver, kidney and cardiovascular, are expected to propel the market for stem cell." Factors that propel the global Stem Cell Market are exhaustive R&D in therapeutic solutions and strong government support for drug discovery & related developments. Governmental support in the form of financial assistance helps fulfill a number of unmet healthcare needs. Rising cases of chronic diseases related to the liver, kidneys, and heart is another prominent factor that increases the popularity of stem cells technology. Stem cells refer to undifferentiated cells that have the capacity to regenerate and thus perform a number of functions. The growing importance of regenerative medical treatment is expected to drive the worldwide Market over the forecast period (2016 to 2024). The four parameters based on which the global stem cell market is categorized are: products, technologies, applications, and geographies. Product-wise, the segments are human embryonic cell, pluripotent, and adult stem. Another term that defines pluripotent stem cells is “master” cells. These cells have the capacity to create cells from all three body layers. Hence, they can produce any tissue or cell that the body has to repair itself. They are self-perpetuating, that is they can develop several copies of themselves. Browse Details of Report @ https://www.hexaresearch.com/research-report/stem-cell-industry Follow Us: Your Catalyst To a Lucrative Business Embryonic stem cells are derived from the undifferentiated inner mass of cells present in a human embryo. Adult or somatic stem cells are found throughout the body and help regenerate damaged or dying cells & tissues. Adult stem cells are by far the most extensively used ones, because the human body can easily accept these cells. Furthermore, the possibility of contamination is also quite low. This segment will continue dominating the global Stem Cell Market during the forecast period. It generated revenues exceeding USD 30 billion in 2013. Based on technologies, the global industry is categorized into cryopreservation, cell production, expansion, and cell acquisition. The overall market was dominated by the cell acquisition segment in 2013. This is the technique of obtaining stem cells from their sources. Cell culture, cloning, and in-vitro fertilization are the different techniques of cell acquisition. Bone marrow harvesting too is an integral part of such a technique. Regenerative medicine, drug discovery, and drug development are the various application areas of the global market. Ongoing trends in medicine suggest that stem cell based treatments are gradually gaining much importance in the management of diseases, such as Huntington’s chorea and Parkinson’s disease. Based on geographies, the global stem cell market is segmented into Europe, Asia Pacific, North America, and Rest of the World. In terms of revenue, North America holds the highest share in the overall market. The region may continue expanding robustly over the forecast period because of widespread adoption of cell based therapies and high R&D investments by the public & private sectors. Asia Pacific too may expand rapidly during the same time because of medical tourism, high disposable incomes, and surging CRO (Contract Res earch Organization) activities. Prominent companies that hold significant shares in the global industry are Angel Biotechnology; California Stem Cell Inc.; Bioheart; Brainstorm Cell Therapeutics; and Celgene Corporation Inc. Stemcells Inc., a California based biopharmaceutical company focuses on the development of purified human neural stem cells (HuCNS-SCs). In November 2016, the company entered a joint collaboration with Microbot Medical Ltd., a medical device company that specializes in developing & designing transformational microrobotic technologies. With the help of highly precise & less invasive surgical solutions, these technologies aim at bettering the quality of life of patients all across the globe. Browse Related Category Market Reports @ https://www.hexaresearch.com/researchcategory/biotechnology-industry Follow Us: Your Catalyst To a Lucrative Business Table of Content of Stem Cell Market Table of Contents Chapter 1. Executive Summary 1.1. Stem Cells - Industry Summary and Critical Success Factors (CSFs) Chapter 2. Stem Cells Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Stem Cells Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Stem Cells Market PESTEL Analysis, 2016 Chapter 3. Stem Cells Product Outlook 3.1. Adult Stem Cells Market Estimates and Forecasts, 2016 - 2024 (USD Million) 3.1.1. Hematopoietic Stem Cells Market Estimates and Forecasts, 2016 - 2024 (USD Million) 3.1.2. Mesenchymal Stem Cells Market Estimates and Forecasts, 2016 - 2024 (USD Million) 3.1.3. Neuronal Stem Cells Market Estimates and Forecasts, 2016 - 2024 (USD Million) 3.1.4. Dental Stem Cells Market Estimates and Forecasts, 2016 - 2024 (USD Million) 3.1.5. Umbilical Cord Stem Cells Market Estimates and Forecasts, 2016 - 2024 (USD Million) 3.2. Human Embryonic Stem Cells Market Estimates and Forecasts, 2016 - 2024 (USD Million) 3.3. Induced Pluripotent Stem Cells Market Estimates and Forecasts, 2016 - 2024 (USD Million) 3.4. Natural Rosette Cells Market Estimates and Forecasts, 2016 - 2024 (USD Million) 3.5. Very Small Embryonic Like Cells Market Estimates and Forecasts, 2016 - 2024 (USD Million) Chapter 4. Stem Cells Application Outlook 4.1. Regenerative Medicine Market Estimates and Forecasts, 2016 - 2024 (USD Million) 4.1.1. Neurology Market Estimates and Forecasts, 2016 - 2024 (USD Million) 4.1.2. Orthopedics Market Estimates and Forecasts, 2016 - 2024 (USD Million) 4.1.3. Oncology Market Estimates and Forecasts, 2016 - 2024 (USD Million) 4.1.4. Hematology Market Estimates and Forecasts, 2016 - 2024 (USD Million) Follow Us: Your Catalyst To a Lucrative Business 4.1.5. Cardiovascular and Myocardial Infraction Market Estimates and Forecasts, 2016 - 2024 (USD Million) 4.1.6. Injuries Market Estimates and Forecasts, 2016 - 2024 (USD Million) 4.1.7. Diabetes Market Estimates and Forecasts, 2016 - 2024 (USD Million) 4.1.8. Liver Disorder Market Estimates and Forecasts, 2016 - 2024 (USD Million) 4.1.9. Incontinence Market Estimates and Forecasts, 2016 - 2024 (USD Million) 4.1.10. Others Market Estimates and Forecasts, 2016 - 2024 (USD Million) 4.2. Drug Discovery and Development Market Estimates and Forecasts, 2016 - 2024 (USD Million) Chapter 5. Stem Cells Technology Outlook 5.1. Cell Acquisition Market Estimates and Forecasts, 2016 - 2024 (USD Million) 5.1.1. Bone Marrow Harvest Market Estimates and Forecasts, 2016 - 2024 (USD Million) 5.1.2. Apheresis Market Estimates and Forecasts, 2016 - 2024 (USD Million) 5.1.3. Umbilical Blood Cord Market Estimates and Forecasts, 2016 - 2024 (USD Million) 5.2. Cell Production Market Estimates and Forecasts, 2016 - 2024 (USD Million) 5.2.1. Therapeutic Cloning Market Estimates and Forecasts, 2016 - 2024 (USD Million) 5.2.2. In Vitro Fertilization Market Estimates and Forecasts, 2016 - 2024 (USD Million) 5.2.3. Isolation Market Estimates and Forecasts, 2016 - 2024 (USD Million) 5.2.4. Cell Culture Market Estimates and Forecasts, 2016 - 2024 (USD Million) 5.3. Cryopreservation Market Estimates and Forecasts, 2016 - 2024 (USD Million) 5.4. Expansion and Sub-Culture Market Estimates and Forecasts, 2016 - 2024 (USD Million) Chapter 6. Stem Cells Regional Outlook 6.1. North America 6.1.1. Market Estimates and Forecasts, by Products, 2016 - 2024 (USD Million) 6.1.2. Market Estimates and Forecasts, by Applications, 2016 - 2024 (USD Million) 6.1.3. Market Estimates and Forecasts, by Technology, 2016 - 2024 (USD Million) 6.2. Europe 6.2.1. Market Estimates and Forecasts, by Products, 2016 - 2024 (USD Million) 6.2.2. Market Estimates and Forecasts, by Applications, 2016 - 2024 (USD Million) 6.2.3. Market Estimates and Forecasts, by Technology, 2016 - 2024 (USD Million) 6.3. Asia Pacific 6.3. Market Estimates and Forecasts, by Products, 2016 - 2024 (USD Million) 6.3.2. Market Estimates and Forecasts, by Applications, 2016 - 2024 (USD Million) 6.3.3. Market Estimates and Forecasts, by Technology, 2016 - 2024 (USD Million) 6.4. RoW 6.4. Market Estimates and Forecasts, by Products, 2016 - 2024 (USD Million) Follow Us: Your Catalyst To a Lucrative Business 6.4.2. Market Estimates and Forecasts, by Applications, 2016 - 2024 (USD Million) 6.4.3. Market Estimates and Forecasts, by Technology, 2016 - 2024 (USD Million) Chapter 7. Stem Cells Competitive landscape 7.1 Advanced Cell Technology Inc. 7.1.1 Company Overview 7.1.2 Financial Performance 7.1.3 Product Benchmarking 7.1.4 Strategic Initiatives 7.2 STEMCELL Technologies Inc. 7.2.1 Company Overview 7.2.2 Financial Performance 7.2.3 Product Benchmarking 7.2.4 Strategic Initiatives 7.3 Cellular Engineering Technologies Inc. 7.3.1 Company Overview 7.3.2 Financial Performance 7.3.3 Product Benchmarking 7.3.4 Strategic Initiatives 7.4 BioTime Inc. 7.4.1 Company Overview 7.4.2 Financial Performance 7.4.3 Product Benchmarking 7.4.4 Strategic Initiatives 7.5 Cellartis AB 7.5.1 Company Overview 7.5.2 Financial Performance 7.5.3 Product Benchmarking 7.5.4 Strategic Initiatives 7.6 Angel Biotechnology 7.6.1 Company Overview 7.6.2 Financial Performance 7.6.3 Product Benchmarking 7.6.4 Strategic Initiatives 7.7 Bioheart Inc. 7.7.1 Company Overview Follow Us: Your Catalyst To a Lucrative Business 7.7.2 Financial Performance 7.7.3 Product Benchmarking 7.7.4 Strategic Initiatives 7.8 BrainStorm Cell Therapeutics 7.8.1 Company Overview 7.8.2 Financial Performance 7.8.3 Product Benchmarking 7.8.4 Strategic Initiatives 7.9 Celgene Corporation 7.9.1 Company Overview 7.9.2 Financial Performance 7.9.3 Product Benchmarking 7.9.4 Strategic Initiatives 7.10 Osiris Therapeutics 7.10.1 Company Overview 7.10.2 Financial Performance 7.10.3 Product Benchmarking 7.10.4 Strategic Initiatives Chapter 8. Methodology and Scope 8.1. Research Methodology 8.2. Research Scope & Assumption 8.3. List of Data Sources Follow Us: Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: hexaresearch1.blogspot.com Follow Us:
Increasing prevalence of chronic diseases such as diseases related to liver, kidney and cardiovascular, are expected to propel the market for stem cell.
© Copyright 2024 Paperzz
